- Source: CP 42,096
CP 42,096 is an analgesic drug which acts as a cannabinoid agonist. It was developed by Pfizer in the 1980s as part of the research that led to the development of levonantradol, and is more potent than THC but less potent than newer compounds such as CP 55,244.
See also
A-41988
CP 47,497
CP 55,940
Canbisol
Hexahydrocannabinol
References
Kata Kunci Pencarian:
- CP 42,096
- CP 55,940
- Hexahydrocannabiphorol
- List of CP cannabinoids
- Tetrahydrocannabinolic acid
- Hexahydrocannabinol
- Conversion of CBD to THC
- Cycloheptyl CP 55,940
- Tetrahydrocannabiphorol
- Synthetic cannabinoids
